Abstract
Candida albicans possesses several molecules or molecular complexes in its cell wall which have the potential of great impact on the host. The microorganism has an ecological niche in warm-blooded animals and is an ordinary human commensal [52]. In the majority of healthy human subjects, Candida commensalism is promptly revealed by the presence of appreciable levels of anti-Candida antibodies as well as by a state of T-cell-mediated, delayed-type hypersensitivity response to fungal antigens. Figure 1 schematically outlines the relationship between C. albicans and man.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alcover A, Ramarli D, Richardson NE, Chang HC, Reinherz EL (1987) Functional and molecular aspects of human T lymphocyte activation via T3-Ti and T11 Pathways. Immunol Rev 95: 5
Ausiello CM, Spagnoli GC, Boccanera M, Casalinuovo I, Malavasi F, Casciani CU, Cassone A (1986) Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. J Med Microbiol 22: 195
Ausiello CM, Palma C, Spagnoli GC, Piazza A, Casciani U, Cassone A (1989) Cytotoxic effectors in human peripheral blood mononuclear induced by a mannoprotein complex of Candida albicans’, a comparison with interleukin-2-activated killer cells. Cell Immunol 121: 349
Baccarini M, Vecchiarelli A, Cassone A, Bistoni F (1985) Killing of yeast, germ-tube and mycelial forms of Candida albicans by murine effectors as measured by a radiolabel release microassay. J Gen Microbiol 131: 505
Boue F, Goujard C, Delfraissy JF, Galanaud P, Hercend T (1989) Regulation of human B cell activation and antibody production by non-major histocompatibility complex-restricted cytotoxic T lymphocytes. Eur J Immunol 19: 529
Braley Mullen H (1982) Differential effect of activated T amplifier cells on B cells responding to thymus-independent type 1 and type 2 antigens. J Immunol 129: 484
Brawner DL, Cutler JE (1986) Ultrastructural and biochemical studies of two dynamically expressed cell surface determinants on Candida albicans. Infect Immun 51: 327
Brawner DL, Cutler JE (1987) Cell surface and intracellular expression of two Candida albicans antigens during in vitro and in vivo growth. Microb Pathogen 2: 249
Brawner DL, Cutler JE (1987) Variability in expression of cell surface antigens of Candida albicans during morphogenesis. Infect Immun 51: 337
Brawner DL, Cutler JE, Bealty WL (1990) Caveats in the investigation of form-specific molecules of Candida albicans. Infect Immun 58: 378
Cabib E (1987) The synthesis and degradation of chitin. In: Meister A (ed) Advances in enzymology and related areas of molecular biology. Wiley, New York, p 59
Cailliez JC, Poulain D (1988) Analyse cytologique de l’expression d’un epitope porte par les glycoproteines excretees par Candida albicans. Ann Inst Pasteur Microbiol 139: 171
Calderone RA, Linehan L, Wadsworth E, Sandberg AL (1988) Identification of C3d receptors on Candida albicans. Infect Immun 56: 252
Carrow EW, Domer JE (1985) Immunoregulation in experimental candidiasis. Specific suppression induced by Candida albicans cell wall glycoprotein. Infect Immun 49: 172
Casanova M, Gil ML, Cardenoso L, Martinez JP, Sentandreu R (1989) Identification of wall-specific synthesized during germ tube formation by Candida albicans. Infect Immun 57: 262
Cassone A (1989) Cell wall of Candida albicans: its functions and its impact on the host. Curr Top Med Mycol 3: 248
Cassone A, Simonetti N, Strippoli V (1973) Ultrastructural changes in the wall during germ-tube formation from blastospores of Candida albicans. J Gen Microbiol HAM
Cassone A, Marconi P, Bistoni F, Mattia E, Sbaraglia G, Garaci E, Bonmassar E (1981) Immunoadjuvant effect of Candida albicans and its cell wall fractions in a mouse lymphoma model. Cancer Immunol Immunother 10: 181
Chaffin WL, Skudlarek J, Morrow K J (1988) Variable expression of a surface determinant during proliferation of Candida albicans. Infect Immun 56: 302
Chattaway FW, Holmes MR, Barlow AJE (1968) Cell wall composition of the mycelial and blastospore forms of Candida albicans. J Gen Microbiol 51: 367
Chen-Wu J, Robbins PW (1990) Chitin synthase gene expression in C. albicans. II Conference on Candida and Candidiasis, Philadelphia (USA), April 1-4, Abstr S14
Chiew YY, Shepherd MG, Sullivan PA (1980) Regulation of chitin synthesis during germ-tube formation in Candida albicans. Arch Microbiol 125: 97
Cooper NR (1988) Complement and infectious agents. Rev Infect Dis 10: S447
Cox RA (1983) Cell-mediated immunity. In: Howard DH (ed) Fungi pathogenic for humans and animals. Part B. Dekker, New York, p 87
Cuff CF, Taub DD, Rogers TJ (1989) The induction of T-suppressor cells with a soluble extract of Candida albicans. Cell Immunol 122: 71
Cutler JD, Lloyd RK (1983) Enhanced antibody response induced by Candida albicans in mice. Infect Immun 38: 1102
Djeu JY, Blanchard KD (1987) Regulation of human polymorphonuclear neutrophil ( PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J Immunol 139: 2761
Djeu JK, Blanchard KD, Richards AL, Friedman H (1988) Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol 141: 4047
Domer JE, Stashak PW, Elkins K, Prescott B, Caldes G, Baker PJ (1986) Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components. Cell Immunol 101: 403
Domer J, Elkins K, Ennist D, Baker P (1988) Modulation of immune responses by surface polysaccharides of Candida albicans. Rev Infect Dis 10: S419
Durandy A, Fischer A, Griscelli C (1983) Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes. J Clin Invest 71: 1602
Durandy A, Fischer A, Charron DJ, Griscelli C (1986) Restriction of the in vitro anti-mannan antibody response by HLA-DQ molecules. Human Immunol 16: 114
Durandy A, Fischer A, Le Deist F, Drouhet E, Griscelli C (1987) Mannan-specific and man- nan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J Clin Immunol 7: 400
Eigentler A, Schultz TF, Larcher C, Breitwieser EM, Myones BL, Petzer A, Dierich MP (1989) Temperature-dependent expression of C3bi-binding protein on Candida albicans and its relationship to human complement receptor type 3. Infect Immun 57: 616
Elorza MV, Murgui A, Sentandreu R (1985) Dimorphism in Candida albicans’, contribution of mannoproteins to the architecture of yeast and mycelial cell walls. J Gen Microbiol 131: 2209
Fischer A, Durandy A, Sterkers G, Griscelli C (1986) Role of the LFA-1 molecule in cellular interactions required for antibody production in humans. J Immunol 136: 3198
Gilmore BJ, Retsinas EM, Lorenz JS, Hostetter MK (1988) An iC3b receptor on Candida albicans’, structure, function, and correlates for pathogenicity. Infect Dis 157: 38
Gopal PK, Shepherd MG, Sullivan PA (1984) Analysis of wall glucans from yeast, hyphal and germ-tube forming cells of Candida albicans. J Gen Microbiol 130: 3295
Hasenclever HF, Mitchell WO (1961) Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans. J Bacteriol 82: 570
Heidenreich F, Diedrich MP (1985) Candida albicans and Candida stellatodidea, in contrast to other Candida species, bind iC3b and C3d but not C3b. Infect Immun 50: 598
Herodin F, Benichou G (1987) Transient suppression of the zymosan-induced chemilumines- cence produced by bone marrow cells during a subcutaneous nonspecific inflammation in the mouse. Leukocyte Biol 42: 76
Hostetter M (1990) Complement receptors on Candida albicans: structure, function and role in pathogenesis. II Conference in Candida and Candidisis, Philadelphia (USA), April 1–4, Abstr S25
Kogan G, Pavliak V, Masler L (1988) Structural studies of mannans from the cell walls of the pathogenic yeasts Candida albicans serotype A and B and Candida parapsilosis. Carbohydr Res 172: 243
Leusch HG (1989) Detection and characterization of two antigens specific for cell walls of Candida albicans mycelial growth phase. Current Microbiol 19: 193
Luzzati AL, Giacomini E, Frugoni P (1988) A two-stage culture system for the induction of antibody-forming cell clones in cultures of normal human blood lymphocytes. Immunol Methods 109: 123
Mangeney M, Fischer A, Le Deist F, Latge JP, Durandy A (1989) Direct activation of human B lymphocytes by Candida albicans-derived mannan antigen. Cell Immunol 122: 329
Mansell PWA, Di Luzio NR, McNamee R, Rowden G, Proctor JW (1976) Recognition factors and non-specific macrophage-activation in the treatment of neoplastic disease. Ann NY Acad Sei 277: 20
Matthews R, Burnie J, Smith D, Clark I, Midgley J, Conolly M, Gazzard B (1988) Candida and AIDS: evidence for protective antibody. Lancet 79: 263
Mattia E, Carruba G, Angiolella L, Cassone A (1982) Induction of germ-tube formation by N-acetyl-D-glucosamine in Candida albicans’, uptake of inducer and germinative response. J Bacteriol 152: 555
McCourtie J, Douglas LJ (1984) Relationship between cell surface composition, adherence and virulence of Candida albicans. Infect Immun 45: 6
Nelson RD, Herron MJ, McCormack RT, Gehrz RC (1985) Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharyde. Infect Immun 49: 172
Odds FC (1987) Candida and candidosis. CRC Crit Rev Microbiol 15: 1
Ohmori T, Tamura K, Wakaiki A, Kawanishi G, Tsuru S, Yadomae T, Nomoto K (1988) Dissociation of a glucan fraction (CO-1) from protein-bound polysaccharide of Cordyceps ophioglossoides and analysis of its antitumor effect. Chem Pharm Bull 36: 4512
Oller MW, Calderone RA (1990) A monoclonal antibody that defines a surface antigen on Candida albicans hyphae cross reacts with yeast cell protoplasts. Infect Immun 58: 625
Podzorski RP, Gray GR, Nelson RD (1990) Different effects on native Candida albicans mannan and mannan-derived oligosaccharydes on antigen-stimulated lymphoproliferation in vitro. J Immunol 144: 707
Poulain D, Hopwood V, Vernes A (1985) Antigenic variability of Candida albicans. CRC Crit Rev Microbiol 12: 223
Reiss E (1985) Cell wall composition. In: Howard DH (ed) Fungi pathogenic for humans and animals. Part B. Dekker, New York, p 57
Rogers TJ (1990) Immunomodulatory products of Candida albicans. Philadelphia (USA), April 1-4, Abstr S29
Saxena A, Hammer CF, Cihlar RL (1989) Analysis of mannans of two relatively avirulent mutant strains of Candida albicans. Infect Immun 57: 413
Scaringi L, Marconi P, Boccanera M, Tissi L, Bistoni F, Cassone A (1988) Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage- mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. J Gen Microbiol 134: 1265
Scaringi L, Cornacchione P, Rosati E, Boccanera M, Cassone A, Bistoni F, Marconi P (1990) Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. Cell Immunol 129: 271
Seifert HS, So M (1981) Genetic mechanisms of bacterial antigenic variation. Microbiol Rev 52: 327
Seljelid R, Bogwald J, Lundwall A (1981) Glycan stimulation of macrophages in vitro. Exp Cell Res 131: 121
Shepherd MG (1987) Cell envelope of Candida albicans. CRC Crit Rev Microbiol 15: 7
Shibata N, Ichikawa T, Tojo M,Takahashi M, Ito N, Okubo Y, Suzuki S (1985) Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch Biochem Biophys 243: 338
Shibata N, Kobayashi H, Tojo M, Suzuki S (1986) Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strann by the action of zymolyase-100T. Arch Biochem Biophys 251: 697
Shibata N, Fukasawa S, Kobayashi H et al. (1989) Structural analysis of phospho-D-mannan- protein complexes isolated from yeast and mold form cells of Candida albicans NIH A-207 serotype-A strain. Carbohydr Res 187: 239
Sietsma JH, Wessels JGH (1979) Evidence for covalent linkages between chitin and ß-glucan in a fungal wall. J Gen Microbiol 114: 99
Soll DR, Langtinem CJ, McDowell J, Hicks J, Galask R (1987) High-frequency switching in Candida strains isolated from vaginitis patients. J Clin Microbiol 25: 1611
Sundstrom PM, Tam MR, Nichols EJ, Kenny GE (1988) Antigenic differences in the surface mannoproteins of Candida albicans as revealed by monoclonal antibodies. Infect Immun 56: 601
Suzuki S (1981) Antigenic determinants. In: Arnold WN (ed) Yeast cell envelopes: biochemistry, biophysics, and ultrastructures, vol 1. CRC, Boca Raton, p 85
Suzuki S, Fukazawa Y (1982) Immunochemical characterization of Candida albicans cell wall antigens: specific determinant of Candida albicans serotype A mannan. Microbiol Immun 26: 387
Suzuki K, Okawa Y, Suzuki S, Suzuki M (1987) Candidacidal effect of peritoneal exudate cells in mice administered with chitin or chitosan: the role of serine protease on the mechanism of oxygen-independent candidacidal effect. Microbiol Immunol 31: 375
Tojo M, Shibata N, Mikami T, Suzuki M, Suzuki S (1987) Participation of peptide moieties in adhesive behavior of antigenic mannans of Candida albicans to the plastic microtiter plate in enzyme-linked immunosorbent assay. Clin Chem 33: 1925
Tojo M, Shibata N, Kobayashi M, Mikami T, Suzuki M, Suzuki S (1988) Preparation of monoclonal antibodies reactive with /?-l,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain. Clin Chem 34: 539
Torosantucci A, Boccanera M, Casalinuovo I, Pellegrini G, Cassone A (1990) Differences in the antigenic expression of immunomodulatory constituents on yeast and mycelial forms of Candida albicans. J Gen Microbiol 136: 1621
Tsuchiya T, Taguchi M, Fukazawa Y, Shinoda T (1984) Serological characterization of yeasts as an aid in identification and classification. Methods Microbiol 16: 76
Vecchiarelli A, Conti E, Puliti M, Blasi E, Puccetti P, Cassone A, Bistoni F (1989) Protective immunity induced by low virulence Candida albicans: cytokine production in the development of the antiinfectious state. Cell Immunol 124: 334
Williams DL, Cook JA, Hofman EO, Di Luzio NR (1978) Protective effect of glucan in experimentally-induced candidiasis. J Reticuloendothel Soc 23: 479
Williams JD, Topley N, Alobaidi HM, Harber MJ (1986) Activation of human polymorphonuclear leucocytes by particulate zymosan is related to both its major carbohydrate components: glucan and mannan. Immunology 58: 117
Wojdani A, Ghoneum M (1987) In vivo augmentation of natural killer cell activity by Candida albicans. Int J Immunopharmacol 9: 827
Wright CD, Bowie JV, Gray GR, Nelson RD (1981) Influence of yeast mannan on human neutrophil functions: inhibition of release of myeloperoxidase related to carbohydrate-binding property of the enzyme. Infect Immun 32: 731
Wright CD, Herron MJ, Gray GR, Holmes B, Nelson RD (1983) Candidacidal activity of myeloperoxidase: mechanism of inhibitory influence of soluble cell wall mannan. Infect Immun 42: 76
Yu RJ, Bishop CT, Cooper FP, Hasenclever HF, Blank F (1967) Structural studies of mannans from Candida albicans (serotype A and B), Candidaparapsilosis, Candida stellatoidea and Candida tropicalis. Can J Chem 45: 2205
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cassone, A., Torosantucci, A. (1991). Immunological Moieties of the Cell Wall. In: Prasad, R. (eds) Candida Albicans. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75253-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-75253-7_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75255-1
Online ISBN: 978-3-642-75253-7
eBook Packages: Springer Book Archive